Sernova Stock price
Is Sernova a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Sernova Stock Analysis
Analyst Opinions
5 Analysts have issued a Sernova forecast:
Analyst Opinions
5 Analysts have issued a Sernova forecast:
Don't miss a Thing! We will send you all news about Sernova directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sernova Stock News
Company Profile
Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded on August 19, 1998 and is headquartered in London, Canada.
| Head office | Canada |
| CEO | Mr. Rigby |
| Employees | 8 |
| Founded | 1998 |
| Website | sernova.com |


